It is widely recognised that the economic downturn has taken a turn for the better; this can be demonstrated across a number of industries, pharmaceutical development being one.
Over the last ten years, the way that the pharmaceutical industry is expected to deliver new drug products to market has seen symbolic change. This shift in process has been driven by a number of significant factors...
Clinical Distribution Manager Rich Nelson discusses opportunities and watch outs for executing studies in the emerging Asia Pacific region
Executive Director of Quality Assurance Sheri Mace discusses the increasing importance of appropriate precautions and handling of potent compounds
Manager of Global Clinical Logistics Dave Lecher identifies various factors to consider when selecting shipping containers to transport valuable clinical trial products to global investigational sites
Associate Director of Clinical Services (Europe) Tim Roberts discusses considerations for sourcing Comparator products in executing global Clinical Trials
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients